Cookies help us improve your ABPI online experience. If you accept their use, continue using our site. or, find out more about cookies.
Ukraine - UK Pharmaceutical Industry Response
We stand in solidarity with the people of Ukraine and condemn the invasion of their country. As an industry dedicated to saving lives, we stand for peace.
ABPI 2021 Code of Practice
The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.
We represent our members, using their insight and experience to tell the story of how they change the lives of millions of people every day.
Life sciences superpower, growing the leading global hub in the UK
A new report from PwC for the ABPI shows that the UK has the potential to be a world-leading hub for medicines development and discovery, home to the future of cutting-edge life sciences innovation.
Clinical trials are important for patients, they are beneficial to the NHS and they are good for the UK economy.
Manufacturing and quality
The UK biopharmaceutical industry has a long and proud record of high quality, reliable manufacturing of medicinal products The UK medicines industry is one of our leading manufacturing sectors, with exports worth £24 billion and generating a trade surplus of £4.9 billion in 2012.
This is the science of developing new tools, standards and approaches to evaluate the efficacy, safety, quality and performance of medical products in order to assess benefit-risk and facilitate a sound and transparent regulatory decision-making.
Pharmacovigilance - drug safety
Drug safety (also known as pharmacovigilance), is the science of detection, assessment, understanding and prevention of side effects which allows us to understand more about the risks and benefits of a medicine.
ABPI Blister Pack Carbon Footprint Tool
The aim of the tool is to provide a quick approximation of the carbon impacts of pharmaceutical tablets in blister packs.